CMV Action Launches a Tender for Research - Estimating the Costs of CMV in the UK

     

CMV Action is today delighted to launch a tender for a research project which is aimed at producing the first complete picture of the economic effects of CMV in the UK.

The results will provide an evidence base for further research, awareness raising, lobbying, campaigning and fundraising. 

The work will involve collecting, collating and analysing data from a wide range of sources and the tender call is being directed to a range of possible research institutions and individuals with a closing date of Friday, 3rd March, 2017.

The project will be overseen by a small, expert Steering Group, including Professor Paul Griffiths, the UK’s leading authority on CMV vaccine research, Dr Chrissie Jones who is leading research to develop an effective antenatal education intervention in the UK and Professor Mark Suhrcke, economic advisor to CMV Action.

For any professionals interested in tendering for this work, or for further information, please contact Sharon Wood sharonwood@cmvaction.org.uk

 

     

Our Stories

Braden-10days-old
I was 14 weeks pregnant when my husband showed me a full torso rash that he had. I was already aware that my immunity to Rubella had dropped so sent him off to the Doctors straight away... Read more
My daughter was born with congenital CMV. I live in the U.S. and I had never heard of CMV before my pregnancy, nor had any of my friends or family who had normal pregnancies. Throughout... Read more

Latest Events

Sunday 22 October
Wednesday 08 November

Registered charity no: 1171773